INTRODUCTION AND OBJECTIVES:
The evaluation of children with a febrile urinary tract infection (UTI) has continued to evolve. A significant paradigm shift occurred in 2011, when the American Academy of Pediatrics (AAP) Guidelines on UTI diagnosis and evaluation recommended against voiding cystourethrogram (VCUG) after a firsttime diagnosis of febrile UTI in children aged 2 to 24 months. The objective of this study was to assess national trends in VCUG utilization over the past 15 years.
METHODS: We performed analysis using Optum Labs Data Warehouse administrative claims data from January 2001 -June 2015. Our cohort included all children age 10 yrs who underwent VCUG for UTI, vesicoureteral reflux, or pyelonephritis. We excluded patients with co-existing diagnoses that involves VCUG as part of standard evaluation. Multiple group interrupted time series analysis (ITSA) with two intervention periods was used to evaluate the impact of the 2011 AAP Guideline on standardized rates of VCUG (Linden, Liden & Yarnold). We designated ages 0 -2 yr as treatment and 6 -10 yr as control groups.
RESULTS: There were 49,311 children identified in our cohort. Post AAP Guideline VCUG rates were significantly decreased compared to pre-intervention VCUG rates for both the 0-2 and 6-10 yr groups (p ¼ <0.0001 and 0.009, respectively). From 2011 to 2015, absolute VCUG utilization rates decreased from 115.8 to 56.5 per 100,000. There was a significant decreasing trend in VCUG utilization rates in the post AAP period (2nd quarter of 2011 -2nd quarter of 2015) for both age groups (p ¼ <0.0001 and <0.0001, respectively). We also identified a significant decrease in VCUG utilization rates between periods 2001 -2007 and 2007 -2011 for both age groups (p ¼ <0.0001 and <0.0001, respectively).
CONCLUSIONS: There was a significant reduction in VCUG utilization rates following publication of the 2011 AAP Guidelines. We also observed a significant decrease in VCUG utilization rates in 2007, the year in which the National Institute for Health and Clinical Excellence (NICE) UTI Guidelines recommended the 00 top-down approach 00 and against routine VCUG testing after febrile UTI. How these changes impacted VUR diagnosis, rates of pyelonephritis, and overall healthcare costs remains to be answered. METHODS: An online survey was distributed to members of the Society for Fetal Urology (SFU) to assess practice patterns surrounding VCUG and CAP use in infants. To ensure face and content validity, the survey was developed by experts in the field and piloted locally. Anonymized responses were analyzed according to HN etiology (isolated HN vs. hydroureteronephrosis [HUN] ) and grade (low vs. high SFU), gender and circumcision status, as well as the use of antibiotics for prevention of post-VCUG UTI.
RESULTS: Response rate was 37% (109/297), with 86 (79%) respondents coming from an academic setting. No difference was observed regarding use of CAP or VCUG indications for unilateral vs. bilateral HN or between genders/circumcision status. In contrast, regardless of HN etiology and gender, an expected difference in CAP use was observed between low grade HN (SFU I/II) vs. high grade HN (SFU III/IV) (p<0.001). Most respondents recommended CAP and VCUG to infants with high grade HUN (Table 1) . For infants with their 1st fUTI and a normal ultrasound (US), we observed that more respondents would order VCUG for males (74%) and females (77%) 0-2 mos. compared to male (54%) and female (53%) infants 2-24 mos. (p<0.01). No significant difference was found when comparing VCUG indications for a 1st fUTI for male and female infants 0-2 and 2-24 mos. with abnormal US. Over 90% of respondents indicated that they would order VCUG regardless of gender or age for this cohort. Despite 85% of clinicians reporting that they had observed a UTI after VCUG, only 31 (28%) empirically treated to avoid a potential post-VCUG UTI. Vol. 197, No. 4S, Supplement, Sunday, May 14, 2017 THE JOURNAL OF UROLOGY â e801
